Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo - PubMed
- ️Wed Jan 01 2014
Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo
Joerg Hucklenbroich et al. Stem Cell Res Ther. 2014.
Abstract
Introduction: Aromatic (ar-) turmerone is a major bioactive compound of the herb Curcuma longa. It has been suggested that ar-turmerone inhibits microglia activation, a property that may be useful in treating neurodegenerative disease. Furthermore, the effects of ar-turmerone on neural stem cells (NSCs) remain to be investigated.
Methods: We exposed primary fetal rat NSCs to various concentrations of ar-turmerone. Thereafter, cell proliferation and differentiation potential were assessed. In vivo, naïve rats were treated with a single intracerebroventricular (i.c.v.) injection of ar-turmerone. Proliferative activity of endogenous NSCs was assessed in vivo, by using noninvasive positron emission tomography (PET) imaging and the tracer [(18)F]-fluoro-L-thymidine ([(18)F]FLT), as well as ex vivo.
Results: In vitro, ar-turmerone increased dose-dependently the number of cultured NSCs, because of an increase in NSC proliferation (P < 0.01). Proliferation data were supported by qPCR-data for Ki-67 mRNA. In vitro as well as in vivo, ar-turmerone promoted neuronal differentiation of NSCs. In vivo, after i.c.v. injection of ar-turmerone, proliferating NSCs were mobilized from the subventricular zone (SVZ) and the hippocampus of adult rats, as demonstrated by both [(18)F]FLT-PET and histology (P < 0.05).
Conclusions: Both in vitro and in vivo data suggest that ar-turmerone induces NSC proliferation. Ar-turmerone thus constitutes a promising candidate to support regeneration in neurologic disease.
Figures

Ar-turmerone increases NSC proliferation in vitro. (A) Ar-turmerone significantly increased the numbers of fetal rat NSCs in primary monolayer culture (mean ± SEM; *P < 0.05, compared with control), dependent on its concentration; representative phase-contrast images are depicted of NSC-treated without (Aʹ) or with (Aʹʹ) 6.25 μg/ml ar-turmerone (bar represents 200 μm). (B) Ar-turmerone significantly increased the number of proliferating NSCs, as assessed by BrdU-incorporation (mean ± SEM; **P < 0.01, compared with control), dependent on its concentration; representative images are depicted of NSCs treated without (Bʹ) or with (Bʹʹ) 3.125 μg/ml ar-turmerone, stained for BrdU-incorporation (bar represents 200 μm). (C) Treating NSCs with 6.25 μg/ml ar-turmerone led to a significant increase in Ki67 mRNA; mRNA levels were normalized to endogenous RPL13a expression and calculated with the 2-ΔCt method; data are depicted as mean ± SEM; *P < 0.05. (D) In high concentrations, ar-turmerone significantly decreased ratio of surviving NSCs within 24 hours of treatment, wheres concentrations between 1.56 and 6.25 μg/ml had no effect (mean ± SEM; *P < 0.05, compared with control).

Ar-turmerone induces neurogenesis in vitro and in vivo. (A) NSCs were allowed to differentiate in the absence (control) or presence of 6.25 μg/ml ar-turmerone. Immunocytochemistry 10 days after growth-factor discontinuation revealed fewer undifferentiated (SOX2+) NSCs in the turmerone-treated group, but more young neurons. The generation of astrocytes and oligodendrocytes was not affected by ar-turmerone (mean ± SEM; **P < 0.01, compared with control). (B) Representative images of differentiated cells include CNPase-positive oligodendrocytes (left), TuJ1-positive young neurons (middle), and GFAP-positive astrocytes (right); bar represents 50 μm. (C) After i.c.v. injection of 3 mg (1 mg/μl) ar-turmerone, significantly more DCX-positive neuroblasts were observed in the SVZ compared with placebo-injected control animals (mean ± SEM; **P < 0.01). (D) Representative staining of DCX-positive neuroblasts in the SVZ (bar represents 50 μm).

Proliferation of endogenous NSC is induced by ar-turmerone in vivo. (A) Staining for proliferating NSCs with anti-BrdU demonstrates that the subventricular zone (SVZ) of rats treated with 3 mg (1 mg/μl) ar-turmerone i.c.v. (left) was wider than that of placebo-treated control animals (Aʹ, right); bar represents 100 μm. (B) Differences in the width of the SVZ were statistically significant (mean ± SEM; *P < 0.05, compared with control). (C) BrdU staining of the hippocampus did not reveal a statistically significant increase in the width of the dentate gyrus, although a trend was noted favoring ar-turmerone (mean ± SEM).

Endogenous NSCs in the neurogenic niches of the rat brain are mobilized by ar-turmerone in vivo. (A) [18F]FLT-PET of a rat brain 1 week after intracerebroventricular injection of ar-turmerone shows enhanced accumulation of [18F]FLT in the subventricular zone compared with (B) Saline-injected control brain, indicating an increase of proliferating endogenous NSCs caused by ar-turmerone. (C) Ar-turmerone-treated rats showed significantly more [18F]FLT accumulation in the SVZ and the hippocampus than did control animals (mean ± SEM; **P < 0.01).
Comment in
-
Poser SW, Androutsellis-Theotokis A. Poser SW, et al. Stem Cell Res Ther. 2014 Nov 17;5(6):127. doi: 10.1186/scrt517. Stem Cell Res Ther. 2014. PMID: 25688994 Free PMC article.
Similar articles
-
Poser SW, Androutsellis-Theotokis A. Poser SW, et al. Stem Cell Res Ther. 2014 Nov 17;5(6):127. doi: 10.1186/scrt517. Stem Cell Res Ther. 2014. PMID: 25688994 Free PMC article.
-
Effects of minocycline on endogenous neural stem cells after experimental stroke.
Rueger MA, Muesken S, Walberer M, Jantzen SU, Schnakenburg K, Backes H, Graf R, Neumaier B, Hoehn M, Fink GR, Schroeter M. Rueger MA, et al. Neuroscience. 2012 Jul 26;215:174-83. doi: 10.1016/j.neuroscience.2012.04.036. Epub 2012 Apr 24. Neuroscience. 2012. PMID: 22542871
-
Cheng SB, Wu LC, Hsieh YC, Wu CH, Chan YJ, Chang LH, Chang CM, Hsu SL, Teng CL, Wu CC. Cheng SB, et al. J Agric Food Chem. 2012 Sep 26;60(38):9620-30. doi: 10.1021/jf301882b. Epub 2012 Sep 12. J Agric Food Chem. 2012. PMID: 22946656
-
Dooley D, Vidal P, Hendrix S. Dooley D, et al. Pharmacol Ther. 2014 Jan;141(1):21-31. doi: 10.1016/j.pharmthera.2013.08.001. Epub 2013 Aug 15. Pharmacol Ther. 2014. PMID: 23954656 Review.
-
Sun L. Sun L. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Apr;32(4):547-51. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012. PMID: 22803441 Review. Chinese.
Cited by
-
The Potential of Curcumin in Treatment of Spinal Cord Injury.
Sanivarapu R, Vallabhaneni V, Verma V. Sanivarapu R, et al. Neurol Res Int. 2016;2016:9468193. doi: 10.1155/2016/9468193. Epub 2016 May 19. Neurol Res Int. 2016. PMID: 27298735 Free PMC article. Review.
-
Nutrichemistry, a means of preventing and healing chronic diseases.
Mulengi JK. Mulengi JK. Electron Physician. 2017 Aug 25;9(8):5043-5048. doi: 10.19082/5043. eCollection 2017 Aug. Electron Physician. 2017. PMID: 28979740 Free PMC article. Review.
-
Walberer M, Rueger MA. Walberer M, et al. Ann Transl Med. 2015 Jun;3(9):123. doi: 10.3978/j.issn.2305-5839.2015.04.02. Ann Transl Med. 2015. PMID: 26207251 Free PMC article. Review.
-
Rogall R, Rabenstein M, Vay S, Bach A, Pikhovych A, Baermann J, Hoehn M, Couillard-Despres S, Fink GR, Schroeter M, Rueger MA. Rogall R, et al. Stem Cell Res Ther. 2018 Jul 4;9(1):182. doi: 10.1186/s13287-018-0927-9. Stem Cell Res Ther. 2018. PMID: 29973246 Free PMC article.
-
R R. R R. Appl Biochem Biotechnol. 2022 Jan;194(1):176-186. doi: 10.1007/s12010-021-03742-2. Epub 2021 Nov 11. Appl Biochem Biotechnol. 2022. PMID: 34762268
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials